In Brief: ACCESS/Tacora
Executive Summary
ACCESS/Tacora: Dallas-based pharmaceutical company ACCESS signs letter of intent April 19 to acquire Seattle drug delivery firm Tacora. Purchase price, up to $14 mil. in stock, is contingent upon Tacora's achievement of certain technology milestones over a 30-month period...